LEP and obesity disorder: An ip administration of leptin (2 mg/kg body weight) effectively reduced food intake and body weight in both control and Myd88ΔGFAP mice fed a STD diet, indicating that astrocyte-specific Myd88 KO did not affect leptin responsiveness under non-obesity conditions.